Harvard Medical School has created more wiggle room in one of its conflict-of-interest rules, after complaints from professors that the policy was hampering them from turning lab discoveries into treatments that could help people. Eric Campbell (Mass General) and Donald Ingber (Wyss Institute) are quoted, and Jeffrey S. Flier (HMS dean) and Robert Mayer (Brigham and Women’s/Dana-Farber) are mentioned.
Trending News
Pilots, Flight Attendants Have Greater Risk of Radiation-Related Cancer Death Than Other Professions
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
New AI Tool Predicts Risk of More Than 300 Diseases With Existing Patient Data
Machine learning reveals complex patterns that can guide care and research